Cargando…
Passive immunization with polyclonal anti-SHIV IgG: partial protection or increased acquisition of heterologous tier 2 SHIV – depending on IgG dose
Autores principales: | Sholukh, AM, Siddappa, NB, Shanmuganathan, V, Lakhashe, SK, Rasmussen, RA, Watkins, JD, Vyas, HK, Mukhtar, MM, Hemashettar, G, Thorat, S, Yoon, JK, Villinger, F, Novembre, FJ, Landucci, G, Forthal, DN, Ratcliffe, S, Robert-Guroff, M, Polonis, V, Montefiori, DC, Ertl, HC, Ruprecht, RM |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3442109/ http://dx.doi.org/10.1186/1742-4690-9-S2-P41 |
Ejemplares similares
-
Passive immunization of macaques with polyclonal anti-SHIV IgG against a heterologous tier 2 SHIV: outcome depends on IgG dose
por: Sholukh, Anton M, et al.
Publicado: (2014) -
Cooperation Between Systemic IgG1 and Mucosal Dimeric IgA2 Monoclonal Anti-HIV Env Antibodies: Passive Immunization Protects Indian Rhesus Macaques Against Mucosal SHIV Challenges
por: Gong, Siqi, et al.
Publicado: (2021) -
Vaccination against Heterologous R5 Clade C SHIV: Prevention of Infection and Correlates of Protection
por: Lakhashe, Samir K., et al.
Publicado: (2011) -
Subclasses of allergen-specific IgG: Serum IgG2 and IgG3 levels are not predicted by IgG1/IgG4 levels
por: MacGlashan, Donald, et al.
Publicado: (2021) -
The antiinflammatory activity of IgG: the intravenous IgG paradox
por: Nimmerjahn, Falk, et al.
Publicado: (2007)